First year PSA kinetics and nadirs after prostate cancer radiotherapy are predictive of overall survival

被引：0
|
作者：
Cheung, R [1 ]
Tucker, S [1 ]
Kuban, D [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1091
引用
收藏
页码：S199 / S200
页数：2
相关论文
共 50 条
  • [41] Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer
    Zanusso, Chiara
    Bortolus, Roberto
    Dreussi, Eva
    Polesel, Jerry
    Montico, Marcella
    Cecchin, Erika
    Gagno, Sara
    Rizzolio, Flavio
    Arcicasa, Mauro
    Novara, Giacomo
    Toffoli, Giuseppe
    ONCOTARGET, 2017, 8 (14) : 22863 - 22875
  • [42] PSA decline after high-dose radiotherapy of localized prostate cancer
    Haverkamp, U
    Prümer, B
    Christian, T
    Benkel, P
    Weber, C
    Gruber, S
    Reimann, P
    Blumberg, J
    Krause, K
    Fischedick, AR
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 52 - 52
  • [43] Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
    Darwis, Narisa Dewi Maulany
    Oike, Takahiro
    Kubo, Nobuteru
    Gondhowiardjo, Soehartati A.
    Ohno, Tatsuya
    CANCERS, 2020, 12 (08) : 1 - 15
  • [44] Predictive value of PSA in prostate cancer is doubtful
    Bonn, D
    LANCET ONCOLOGY, 2002, 3 (03): : 130 - 130
  • [45] Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer
    E. Lambert
    M. Goossens
    E. Palagonia
    J. Vollemaere
    E. Mazzone
    P. Dell’Oglio
    E. Pauwels
    R. De Groote
    F. D’Hondt
    A. Mottrie
    G. De Naeyer
    P. Schatteman
    World Journal of Urology, 2021, 39 : 2621 - 2626
  • [46] Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer
    Lambert, E.
    Goossens, M.
    Palagonia, E.
    Vollemaere, J.
    Mazzone, E.
    Dell'Oglio, P.
    Pauwels, E.
    De Groote, R.
    D'Hondt, F.
    Mottrie, A.
    De Naeyer, G.
    Schatteman, P.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (07) : 2621 - 2626
  • [47] FREE PSA KINETICS FOR PROSTATE CANCER DIAGNOSIS
    Benecchi, Luigi
    Uliano, Nicoletta
    Pastizzaro, Carmelo Destro
    Pieri, Anna Maria
    Potenzoni, Michele
    Arnaudi, Roberto
    Prati, Andrea
    Savino, Antonio
    Potenzoni, Domenico
    ANTICANCER RESEARCH, 2011, 31 (05) : 1914 - 1914
  • [48] PSA kinetics after iodine-125 seed implantation in prostate cancer
    Kocher, M
    Bendel, M
    Weise, C
    Haupt, G
    Engelmann, U
    Müller, RP
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 89 - 89
  • [49] Apalutamide and Overall Survival in Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Chowdhury, Simon
    Oudard, Stephane
    Hadaschik, Boris A.
    Graff, Julie N.
    Olmos, David
    Mainwaring, Paul N.
    Lee, Ji Youl
    Uemura, Hiroji
    De Porre, Peter
    Smith, Andressa A.
    Brookman-May, Sabine D.
    Li, Susan
    Zhang, Ke
    Rooney, Brendan
    Lopez-Gitlitz, Angela
    Small, Eric J.
    EUROPEAN UROLOGY, 2021, 79 (01) : 150 - 158
  • [50] Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy
    Incognito, LS
    Cazares, LH
    Schellhammer, PF
    Kuban, DA
    Van Dyk, EO
    Moriarty, RP
    Wright, GL
    Somers, KD
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (04) : 761 - 769
12345